Immunosuppressive effects of mesenchymal stem cells on lung B cell gene expression in LPS-induced acute lung injury

Abstract

Background Immune system disorders play important roles in acute lung injury (ALI), and mesenchymal stem cell (MSC) treatment can reduce inflammation during ALI. In this study, we compared the changes in lung B cells during MSC treatment. Methods We investigated the effects of MSCs on lung B cells in a mouse model of lipopolysaccharide (LPS)-induced ALI. MSCs were administered intratracheally 4 h after LPS. As vehicle-treated controls, mice were treated with phosphate-buffered saline (PBS) containing 2% C57BL/6 (PBS group). Histopathological changes, survival rate, inflammatory factor levels, and the number of neutrophils in bronchoalveolar lavage fluid (BALF) were determined. Single-cell RNA sequencing (scRNA-Seq) analysis was performed to evaluate the transcriptional changes in lung B cells between the PBS, LPS, and LPS/MSC groups on days 3 and 7. Results MSC treatment ameliorated LPS-induced ALI, as indicated by the reductions in mortality, the levels of chemokines and cytokines in BALF, and the severity of lung tissue histopathology in ALI mice. Lung B cells in the PBS group remained undifferentiated and had an inhibitory phenotype. Based on our scRNA-Seq results, the differentially expressed genes (DEGs) in lung B cells in both the PBS group and LPS group were involved in chemotaxis processes and some proinflammatory pathways. MSC treatment inhibited the expression of chemokine genes that were upregulated by LPS and were related to the recruitment of neutrophils into lung tissues. Immunoglobulin-related gene expression was decreased in lung B cells of mice treated with LPS/MSC for 7 days. The DEGs regulated by MSCs were enriched in biological processes, including humoral immune response and apoptotic signaling. Conclusions Lung B cells played an important role in the effects of treatment of ALI with MSCs. These observations provide new insights into the mechanisms underlying the effects of MSC treatment for ALI.

Exosomes from human umbilical cord mesenchymal stem cells attenuate the inflammation of severe steroid-resistant asthma by reshaping macrophage polarization

“…MSCs have been shown to interact with all innate immune cells and promote anti-inflammatory response [ 31 ]. In animal models and pre-clinical experimental studies, MSC transplantation has a beneficial therapeutic effect on pulmonary inflammatory diseases [ 13 , 14 , 32 ]. However, there are still many drawbacks and risks in MSC transplant therapies [ 33 ].…”

Immunomodulatory Properties of Mesenchymal Stromal Cells: An Update

“…Another important soluble factor is IL1-RA, as MSCs from IL1-RA-deficient mice were unable to inhibit B-cell differentiation ( Luz-Crawford et al, 2016 ). In a mouse model of LPS-induced acute lung injury, MSC treatment blocked the expression of genes involved in chemokine signaling and immunoglobulin expression by B cells ( Feng et al, 2020 ). While multiple studies support the MSC-induced inhibition of B cell antibody secretion, others argue that MSCs actually promote their antibody production as well as survival, proliferation, and differentiation ( Traggiai et al, 2008 ).…”

Current Status of Cell-Based Therapies for COVID-19: Evidence From Mesenchymal Stromal Cells in Sepsis and ARDS

“…Furthermore, the immunosuppressive capacity of Tregs can inhibit the production of pro-inflammatory cytokines such as IL-6 and TNF-a (93, 94). In addition, MSCs exhibited immunosuppressive effects by reducing the level of immunoglobulin production and chemokines that are related to recruiting neutrophils in lung B cells (95). When IL-1b was pretreated, the immunomodulatory properties of MSCs could be effectively enhanced (96).…”